May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Anatomic and Visual Outcomes of Non-Infectious Endophthalmitis After Intravitreal Triamcinolone
Author Affiliations & Notes
  • S. J. Yoon
    Ophthalmology, New England Eye Center, Boston, Massachusetts
  • D. Y. Rhee
    Ophthalmology, New England Eye Center, Boston, Massachusetts
  • J. L. Marx
    Ophthalmology, Lahey Clinic, Burlington, Massachusetts
  • G. R. Blaha
    Ophthalmology, Lahey Clinic, Burlington, Massachusetts
  • A. H. Rogers
    Ophthalmology, New England Eye Center, Boston, Massachusetts
  • C. R. Baumal
    Ophthalmology, New England Eye Center, Boston, Massachusetts
  • E. Reichel
    Ophthalmology, New England Eye Center, Boston, Massachusetts
  • J. S. Duker
    Ophthalmology, New England Eye Center, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  S.J. Yoon, None; D.Y. Rhee, None; J.L. Marx, None; G.R. Blaha, None; A.H. Rogers, None; C.R. Baumal, None; E. Reichel, None; J.S. Duker, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 964. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. J. Yoon, D. Y. Rhee, J. L. Marx, G. R. Blaha, A. H. Rogers, C. R. Baumal, E. Reichel, J. S. Duker; Anatomic and Visual Outcomes of Non-Infectious Endophthalmitis After Intravitreal Triamcinolone. Invest. Ophthalmol. Vis. Sci. 2008;49(13):964. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To describe the anatomic and visual outcomes of patients whodeveloped non-infectious endophthalmitis following injectionof intravitreal triamcinolone acetonide.

 
Methods:
 

A noncomparative retrospective case series was conducted inseventeen eyes of seventeen patients that developed non-infectiousendophthalmitis following intravitreal triamcinolone. Evaluationsof patients used Snellen visual acuity and mean foveal thicknessby ocular coherence tomography. Evaluations took place on theday of injection, presentation of non-infectious endophthalmitis,time of clearance of inflammation, and on follow-up exam.

 
Results:
 

Mean visual acuity and mean foveal thickness on the day of injectionof intravitreal triamcinolone were 20/132 (logMAR 0.8206) and432µm respectively. Mean visual acuity at time of non-infectiousendophthalmitis (mean=1.9 days) was 20/4444 (logMAR 2.3508).At follow-up (mean=57.6 days) visual acuity and mean fovealthickness was 20/56 (logMAR 0.4435) and 301µm respectively.

 
Conclusions:
 

Visual acuity and mean foveal thickness in all patients withnon-infectious endophthalmitis after intravitreal triamcinoloneimproved to better than pre-injection levels in this series.No patient suffered long term visual loss from non-infectiousendophthalmitis. Non-infectious endophthalmitis after intravitrealtriamcinolone may not exclude good visual and anatomic prognoses.  

 

 
Keywords: endophthalmitis • corticosteroids • edema 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×